Horsham: Johnson & Johnson has announced that the company has received approval from the U.S. Food and Drug Administration ...
The FDA has accepted Alvotech (NASDAQ:ALVO) and Teva's (NYSE:TEVA) Biologics License Applications for AVT05, their proposed biosimilar to the anti-inflammatory drugs Simponi and Simponi Aria. Review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback